The jury has been out on whether long-term outcomes have improved for children with heterotaxy syndrome. A new investigation offers some answers.
The long-term effects of heterotaxy syndrome are little understood and previous studies offer conflicting results. An investigation in Pediatrics wanted to describe the long-term outcomes and how outcomes may have changed over time.1
The investigators included chidren with heterotaxy syndrome who been born between 1985 and 2014 who had required any cardiac care, excluding initial palliation, at a hospital. The patients were split into 4 birth eras and survival over time was compared. For patients who underwent surgery, the link between mortality and surgical pathway, univentricular versus biventricular repair, was examined following adjusting for baseline cofounders.
A total of 264 patients with 118 had asplenia and 146 had polysplenia syndrome. Overall the mortality was 40.2% after a median follow-up of 10.2 years. Following multivariable analysis, coarctation, univentricular circulation, asplenia phenotype, mild atrioventricular valve regurgitation, and pulmonary vein stenosis were linked with mortality. However, birth era was not associated with mortality. For patients who had surgery, univentricular repair was linked to mortality following adjustment.
The researchers concluded that outcomes remain poor for patients with heterotaxy syndrome and little improvement has been seen since the early 1990s. They also found that totally anomalous pulmonary venous connection and univentricular circulation were linked to a worse prognosis.
Reference
1. Banka P, Adar A, Schaetzle B, Sleeper L, Emani S, Geva T. Changes in prognosis of heterotaxy syndrome over time. Pediatrics. 2020:146(1):e20193345. doi:10.1542/peds.2019-3345
The benefits of concurrent fetal and maternal heart rate monitoring
April 17th 2024A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Meet the board: Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
April 22nd 2022In the latest episode of our podcast series, Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN shares why she got into medicine, the myths of pediatric, and what the future may hold for the specialty.
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.